Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LXRX stock, giving a Buy rating yesterday.Invest with Confidence: ...

Our goal is to provide novel therapeutic modalities that would not only alleviate neuropathic pain in patients with diabetes but, even more importantly, also halt its progression without causing ...

Transcutaneous electrical nerve stimulation (TENS) may help provide pain relief for people with diabetic neuropathy. However, more research is necessary. Some research suggests that high and low ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

the event will offer an in-depth overview on LX9211 for the treatment of diabetic peripheral neuropathic pain (DPNP), featuring remarks from Lexicon leaders including: In addition to presentations ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

EC-5026 is under clinical development by Eicosis and currently in Phase I for Diabetic Neuropathic Pain. According to GlobalData, Phase I drugs for Diabetic Neuropathic Pain have a 94% phase ...

Certain conditions, such as diabetes, may increase your risk of neuropathy, which could lead to neuropathic pain. CBD lotions, creams, and salves may help reduce aches and pains. It’s unclear ...

Diabetic Peripheral Neuropathy (DPN): A type of nerve damage that occurs in people with diabetes, leading to pain, numbness, and weakness, particularly in the extremities. Hyperglycemia ...

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...